Michael A. Gillette
Molecular Biology · 2005–2020
A researcher in the Science corpus: 4 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 105 citations into it; #10,966 of 17,773 by trust here, #637 by citations
- Spectroscopy — 23 citations into it
Whom Michael A. Gillette trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Michael A. Gillette overall
Papers from Michael A. Gillette's perspective
Ordered by how strongly the researchers Michael A. Gillette trusts endorse each paper. Same corpus, a different order for every researcher.
- Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS (Proceedings of the National Academy of Sciences of the United States of America)
- The Need for Guidelines in Publication of Peptide and Protein Identification Data (Molecular & Cellular Proteomics)
- Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
- Characterizing the cancer genome in lung adenocarcinoma (Nature)
- Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). (Journal of Proteome Research)
- Colonic epithelial cell diversity in health and inflammatory bowel disease (Nature)
- RET, ROS1 and ALK fusions in lung cancer (Nature Medicine)
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (Science)
- Somatic mutations affect key pathways in lung adenocarcinoma (Nature)
- Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? (Nature Reviews. Cancer)
Their papers
- From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) — 44,350 citations
- Proteogenomic characterization of human colon and rectal cancer (2014) — 1,339 citations
- Protein biomarker discovery and validation: the long and uncertain path to clinical utility (2006) — 1,820 citations
- Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma (2020) — 669 citations